Nicole Sweeny
Chief Commercial Officer; Director · 7 filings · Latest: Jun 26, 2026
KalVista Pharmaceuticals, Inc.
Monopar Therapeutics
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KALV | Nicole Sweeny | Chief Commercial Officer | May 26, 2026 | Sale | $26.78 | 1,489 | $39.9K | 59,291 | |
KALV | Nicole Sweeny | Chief Commercial Officer | May 22, 2026 | Option Exercise | — | 5,000 | — | 60,780 | |
KALV | Nicole Sweeny | Chief Commercial Officer | May 22, 2026 | Sale | $26.78 | 1,861 | $49.8K | 55,780 | |
KALV | Nicole Sweeny | Chief Commercial Officer | May 21, 2026 | Option Exercise | — | 6,250 | — | 57,641 | |
KALV | Nicole Sweeny | Chief Commercial Officer | Apr 17, 2026 | Sale | $20.22 | 1,862 | $37.6K | 51,391 | |
KALV | Nicole Sweeny | Chief Commercial Officer | Apr 16, 2026 | Option Exercise | — | 6,250 | — | 53,253 | |
KALV | Nicole Sweeny | Chief Commercial Officer | Feb 23, 2026 | Sale | $15.57 | 3,975 | $61.9K | 47,003 | |
KALV | Nicole Sweeny | Chief Commercial Officer | Feb 22, 2026 | Option Exercise | — | 5,000 | — | 50,978 | |
KALV | Nicole Sweeny | Chief Commercial Officer | Feb 21, 2026 | Option Exercise | — | 6,250 | — | 45,978 |